Published in Am J Pathol on February 01, 1990
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
VEGF(165) mediates glomerular endothelial repair. J Clin Invest (1999) 2.18
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med (1992) 1.98
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64
Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest (1993) 1.63
Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol (1999) 1.42
Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol (1995) 1.41
Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol (1991) 1.31
A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am J Pathol (2001) 1.30
Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Clin Invest (1995) 1.20
Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis. Am J Pathol (1997) 1.10
Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest (1992) 1.09
Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol (1992) 1.07
Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol (1993) 1.06
Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol (2007) 1.05
Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection. Am J Pathol (1993) 1.03
Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Proc Natl Acad Sci U S A (1999) 0.96
Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J Clin Invest (1998) 0.94
SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro. Am J Pathol (1996) 0.93
Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen. Clin Exp Immunol (1992) 0.93
Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis. Clin Exp Immunol (1997) 0.88
Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis. Am J Pathol (1993) 0.88
New insights into mechanisms of immune glomerular injury. West J Med (1994) 0.87
Bioinformatics analysis of proteomic profiles during the process of anti-Thy1 nephritis. Mol Cell Proteomics (2011) 0.86
Glomerular mesangial cell migration. Response to platelet secretory products. Am J Pathol (1991) 0.84
Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3. Clin Exp Immunol (1992) 0.83
Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome. Am J Pathol (1992) 0.83
PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation. Clin Exp Immunol (2006) 0.82
Attenuation of anti-Thy1 glomerulonephritis in the rat by anti-inflammatory platelet-inhibiting agents. Am J Pathol (1993) 0.81
Effects of diadenosine polyphosphates on glomerular volume. Br J Pharmacol (2005) 0.77
Purification with monoclonal antibody of a predominant leukocyte-common antigen and glycoprotein from rat thymocytes. Eur J Immunol (1979) 3.69
Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol (1989) 3.43
Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res (1986) 2.74
Iodination by human polymorphonuclear leukocytes: a re-evaluation. J Lab Clin Med (1977) 2.45
Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res (1987) 2.13
Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J Exp Med (1978) 1.98
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int (1987) 1.78
Cellular aspects of rabbit Masugi nephritis. II. Progressive glomerular injuries with crescent formation. Lab Invest (1972) 1.52
Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol (1987) 1.50
Cell culture approaches to the analysis of glomerular inflammation. Kidney Int (1986) 1.37
Production of platelet-derived growth factorlike protein by rat mesangial cells in culture. J Clin Invest (1987) 1.24
Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest (1988) 1.20
Cultured human endothelial cells synthesize a plasma membrane protein complex immunologically related to the platelet glycoprotein IIb/IIIa complex. Blood (1986) 1.09
The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmacol Rev (1977) 1.05
The role of platelets and polycationic mediators in glomerular vascular injury. Semin Nephrol (1985) 1.02
Thy-1 glycoprotein: structure, distribution, and ontogeny. Lab Invest (1986) 0.98
Focal mesangial proliferative glomerulonephritis in the rat caused by Habu snake venom: the role of platelets. Br J Exp Pathol (1979) 0.98
Identification of lymphohemopoietic cells in the kidneys of normal rats. Am J Pathol (1986) 0.98
Effect of indomethacin, sulfinpyrazone and dipyridamole on the release of the platelet-derived growth factor. Thromb Res (1979) 0.89
Osteopontin is expressed in human aortic valvular lesions. Circulation (1995) 4.16
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest (1993) 2.60
Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol (1996) 2.60
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol (2001) 2.18
Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation (1996) 2.05
Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int (1992) 2.02
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med (1992) 1.98
Autopsy findings in the acquired immune deficiency syndrome. JAMA (1984) 1.91
Renal injury from angiotensin II-mediated hypertension. Hypertension (1992) 1.88
Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations. Am J Kidney Dis (1999) 1.81
Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation (1995) 1.73
Expression of the cyclin kinase inhibitor, p27kip1, in developing and mature human kidney. Kidney Int (1998) 1.66
Spindle cell lipoma of the oral cavity. Report of a rare intramuscular case with fine needle aspiration findings. Acta Cytol (2001) 1.65
Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ Res (1995) 1.64
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci U S A (1991) 1.64
Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest (1993) 1.63
Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int (1991) 1.61
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum Mol Genet (2000) 1.58
Characterization of rat mast cell granule proteins. Arch Biochem Biophys (1976) 1.57
Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation. Am J Kidney Dis (1996) 1.55
Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation (1998) 1.52
Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int (1998) 1.50
Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int (2000) 1.49
Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res (1993) 1.49
Secretory phenotypes of endothelial cells in culture: comparison of aortic, venous, capillary, and corneal endothelium. Arteriosclerosis (1982) 1.49
Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidney. Kidney Int (1999) 1.49
Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies. Am J Kidney Dis (1999) 1.46
Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol (2001) 1.45
The activated mesangial cell: a glomerular "myofibroblast"? J Am Soc Nephrol (1992) 1.44
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int (1996) 1.43
Renal manifestations of hepatitis C virus infection. Kidney Int (1994) 1.43
Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest (1986) 1.42
Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis (2001) 1.42
Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol (1995) 1.41
Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int (1995) 1.41
Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int (1991) 1.39
The human neutrophil serine proteinases, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med (1988) 1.35
The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol (1985) 1.32
Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol (1991) 1.31
Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol (1993) 1.30
Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest (1992) 1.26
Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: a podocyte disease. Kidney Int (1997) 1.25
Detection of terminal complement components in experimental immune glomerular injury. Kidney Int (1984) 1.24
An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am J Pathol (1989) 1.23
A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture. Biochemistry (1980) 1.23
Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features. Kidney Int (1987) 1.22
Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest (1988) 1.20
Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis (1989) 1.19
Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas. Hum Pathol (1992) 1.19
Gastric choriocarcinoma and yolk sac tumor in a man: observations about its possible origin. Hum Pathol (1985) 1.19
Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest (1992) 1.15
Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int (1994) 1.15
A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy. Clin Nephrol (2006) 1.14
Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int (1994) 1.14
Endobronchial metastasis from cancer of the breast. Chest (1978) 1.11
Neoplasia and glomerular injury. Kidney Int (1986) 1.10
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09
Differential uptake of human beta-glucuronidase isoenzymes from spleen by deficient fibroblasts. Biochem Biophys Res Commun (1974) 1.09
Biosynthesis of type V procollagen by A204, a human rhabdomyosarcoma cell line. J Biol Chem (1982) 1.09
Rat glomerular mesangial cells synthesize basic fibroblast growth factor. Release, upregulated synthesis, and mitogenicity in mesangial proliferative glomerulonephritis. J Clin Invest (1992) 1.09
Glomerulonephritis with anti-glomerular basement membrane antibody during pregnancy: potential role of the placenta in amelioration of disease. Am J Kidney Dis (1995) 1.09
Podocyte expression of the CDK-inhibitor p57 during development and disease. Kidney Int (2001) 1.07
Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol (1993) 1.06
A new model of renal microvascular endothelial injury. Kidney Int (1997) 1.06
Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. Gynecol Oncol (2013) 1.04
Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int (1996) 1.04
Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection. Am J Pathol (1993) 1.03
Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am J Pathol (1994) 1.02
Single light chain subclass (kappa chain) immunoglobulin deposition in glomerulonephritis. Hum Pathol (1985) 1.01
Subgross pathologic features and incidence of radial scars in the breast. Hum Pathol (1984) 1.01
Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol (2000) 1.01
Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol (1994) 1.00
Susceptibility of type V collagen to neutral proteases: evidence that the major molecular species is a thrombin-sensitive heteropolymer, [alpha 1(V)]2 alpha 2(V). Biochemistry (1981) 1.00
The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int (1999) 1.00
Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochem J (1997) 1.00
Osteopontin expression in human crescentic glomerulonephritis. Kidney Int (2000) 0.99
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int (1995) 0.98
Computerized tomography of cranial sutures. Part 2: Abnormalities of sutures and skull deformity in craniosynostosis. J Neurosurg (1984) 0.98
Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J Am Soc Nephrol (2000) 0.98
Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease. Kidney Int (2000) 0.97
CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats. J Am Soc Nephrol (1998) 0.97
SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int (1996) 0.97
Renal proliferative and phenotypic changes in rats with two-kidney, one-clip Goldblatt hypertension. Am J Hypertens (1994) 0.96
The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis. Kidney Int (1999) 0.95
Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome. Immunohistochemical study and review of the literature. Cancer (1984) 0.95